MedPath

BIT Pharma GmbH

Ownership
Private
Employees
-
Market Cap
-
Website
https://www.bit-pharma.com/

Clinical Trials

2

Active:1
Completed:1

Trial Phases

2 Phases

Phase 1:1
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (50.0%)
Phase 2
1 (50.0%)

A Safety and Efficacy Study of NicaPlant® in Aneurysmal Subarachnoid Haemorrhage Patients Undergoing Aneurysm Clipping

Phase 2
Completed
Conditions
Aneurysmal Subarachnoid Hemorrhage
Interventions
Other: Standard of care
First Posted Date
2020-02-13
Last Posted Date
2023-07-12
Lead Sponsor
BIT Pharma GmbH
Target Recruit Count
41
Registration Number
NCT04269408
Locations
🇦🇹

Universitätsklinik Innsbruck, Universitätsklinik für Neurochirurgie, Innsbruck, Austria

🇦🇹

Kepler Universitätsklinikum, Universitätsklinik für Neurochirurgie, Linz, Austria

🇦🇹

Medizinische Universität Wien, Universitätsklinik für Neurochirurgie, Vienna, Austria

and more 3 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.